Trial Profile
The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Subjects With Type 2 Diabetes. A 26-week, Randomised, Open-label, Active Comparator, Three-armed, Parallel-group, Multi-centre, Multinational Trial With a 52-week Extension.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Apr 2022
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Sitagliptin
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Registrational; Therapeutic Use
- Sponsors Novo Nordisk
- 14 Jul 2016 Results of a meta-analysis in African-American/black people with T2DM from seven phase III trials (NCT00395746, NCT00614120, NCT00294723, NCT00333151, NCT00331851, NCT00518882 and NCT00700817), published in the Diabetic Medicine
- 22 Jun 2012 Additional trial location added as reported by ClinicalTrials.gov.
- 08 Dec 2011 Extension-phase results presented at the 21st World Diabetes Congress.